CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 157 enrolled
Drug / intervention
Real-time CGM datadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03068273
NCT03068273N/ACompleted

Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign

Scripps Whittier Diabetes Institute·interventional·Posted Mar 1, 2017·Updated Oct 15, 2025

In Brief

A clinical study evaluating Real-time CGM data for Diabetes Mellitus, Type 1 and Diabetes Mellitus, Type 2. Completed, enrolled 157 participants across 1 site.

Detailed Summary

This program will provide patients with type 1 and high risk type 2 diabetes the safest hospitalization by using wireless continuous glucose monitoring devices (CGM) to track their glucose parameters in real-time similar to other continuously monitored vital signs. The CGM will inform a team of health professionals who will monitor the patients' progress, communicate recommendations, and be available for discussion when recommended targets are not achieved. Health teams will utilize sensor results in addition to existing electronic medical records data to evaluate progress and manage care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 1, 2017
Enrollment StartMay 1, 2015
Primary CompletionMar 17, 2020
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 9.3 years ago

Interventions

Real-time CGM datadevice